GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,518,000 | -1.5% | 57,849 | -1.2% | 0.04% | +8.6% |
Q1 2022 | $2,557,000 | +7.8% | 58,571 | +8.9% | 0.04% | -2.8% |
Q4 2021 | $2,372,000 | +32.5% | 53,784 | +14.9% | 0.04% | +20.0% |
Q3 2021 | $1,790,000 | +15.7% | 46,811 | +20.5% | 0.03% | +7.1% |
Q2 2021 | $1,547,000 | +10.8% | 38,859 | -0.6% | 0.03% | -6.7% |
Q1 2021 | $1,396,000 | +1.9% | 39,102 | +5.2% | 0.03% | -9.1% |
Q4 2020 | $1,370,000 | -47.0% | 37,171 | -45.7% | 0.03% | -19.5% |
Q3 2020 | $2,586,000 | +103.5% | 68,497 | +119.8% | 0.04% | +10.8% |
Q2 2020 | $1,271,000 | +11.9% | 31,162 | +4.3% | 0.04% | +8.8% |
Q1 2020 | $1,136,000 | -15.7% | 29,888 | +4.1% | 0.03% | +9.7% |
Q4 2019 | $1,347,000 | +286.0% | 28,719 | +250.0% | 0.03% | +121.4% |
Q3 2019 | $349,000 | -8.2% | 8,206 | -13.6% | 0.01% | -17.6% |
Q2 2019 | $380,000 | 0.0% | 9,496 | +4.4% | 0.02% | -15.0% |
Q1 2019 | $380,000 | +8.6% | 9,095 | +0.6% | 0.02% | -66.1% |
Q4 2018 | $350,000 | – | 9,043 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |